Common variable immunodeficiency and autoimmunity--an inconvenient truth.

Area of Science:

• Immunology
• Clinical Medicine
• Genetics

Background:

• Common Variable Immunodeficiency (CVID) is characterized by impaired antibody production and increased susceptibility to infections.
• Coexisting conditions in CVID patients frequently include bronchiectasis, malignancies, and autoimmune diseases, affecting up to 20% of cases.
• Autoimmune cytopenia is the most prevalent autoimmune condition in CVID, though others like rheumatoid arthritis and lupus are also reported.

Purpose of the Study:

• To explore the complex relationship between immunodeficiency and autoimmunity in CVID.
• To elucidate the cellular and molecular mechanisms underlying the paradoxical coexistence of hypo- and hyper-immune states in CVID.
• To highlight the implications of these findings for individualized CVID treatment strategies.

Main Methods:

• Review of existing literature on CVID comorbidities and immunological alterations.
• Analysis of cellular defects in T and B cells associated with CVID.
• Examination of regulatory T cell (Treg) function, T cell apoptosis, and cytokine gene polymorphisms.

Main Results:

• CVID involves T and B cell abnormalities, including downregulated Treg cells, accelerated T cell apoptosis, and altered cytokine production.
• Increased production of autoreactive B cells contributes to the development of autoimmunity in CVID.
• The interplay between these immune derangements explains both the immunodeficiency and the propensity for autoimmunity.

Conclusions:

• The paradoxical coexistence of immunodeficiency and autoimmunity in CVID is explained by complex immune cell interactions and signaling pathways.
• CVID is a heterogeneous condition with variable clinical manifestations, suggesting it represents a spectrum of diseases.
• Personalized treatment approaches tailored to individual patient profiles are crucial for effective CVID management.